Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie (ABBV) Files for Rinvoq in Giant Cell Arteritis in US & EU
12:15pm, Monday, 15'th Jul 2024
AbbVie (ABBV) files regulatory applications to the FDA and the EMA, seeking approval for a new indication of Rinvoq, giant cell arteritis.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
06:38am, Monday, 15'th Jul 2024
Litigation concerns have pushed Johnson & Johnson to an appealing price. Dividend investors will love AbbVie's high yield and resilient growth.
Wall Street Brunch: Trump 'Fine' After Shooting
09:05am, Sunday, 14'th Jul 2024
Trump confirms he is "fine" after assassination attempt during rally in Pennsylvania, suspect dead. Global leaders condemn violence, wish Trump speedy recovery.
3 Dividend Growth Stocks to Buy and Hold
06:30am, Sunday, 14'th Jul 2024
AbbVie is poised to keep a 52-year streak of dividend hikes going. Amgen offers more than a dividend with its promising pipeline.
3 High-Yield Dividend Stocks That Still Look Like Bargains
04:27am, Sunday, 14'th Jul 2024
Johnson & Johnson and AbbVie produce reliable earnings driven by sales of patent-protected drugs. Real estate investment trust Agree Realty makes monthly dividend payments.
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Giant Cell Arteritis
08:30am, Friday, 12'th Jul 2024
Submissions are supported by the Phase 3 SELECT-GCA study demonstrating upadacitinib 15 mg with a 26-week steroid taper regimen achieved the primary endpoint of sustained remission from week 12 throug
AbbVie (ABBV) Up 24% in a Year: Buy, Sell or Hold the Stock?
11:16am, Thursday, 11'th Jul 2024
Investors who own AbbVie's (ABBV) stock may stay invested as the company has faced its biggest challenge, Humira's patent cliff- quite well and looks set to return to robust growth next year.
5 High-Yield Dividend Champions to Buy Hand Over Fist Now
10:27am, Thursday, 11'th Jul 2024
Dividend stocks are a favorite among investors for good reasons.
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
10:06am, Thursday, 11'th Jul 2024
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AbbVie Announces Appointment of Roopal Thakkar, M.D. as Executive Vice President, Research & Development and Chief Scientific Officer
08:00am, Wednesday, 10'th Jul 2024
NORTH CHICAGO, Ill. , July 10, 2024 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced that Roopal Thakkar, M.D.
The 7 Best Warren Buffett Stocks to Buy in July 2024
07:40am, Tuesday, 09'th Jul 2024
I just read an article that quoted billionaire hedge fund manager, David Einhorn, as saying value investing was dead. Since I'm writing about the best Warren Buffett stocks, that thought piqued my int
The Smartest Dividend Stocks to Buy With $250 Right Now
05:50am, Monday, 08'th Jul 2024
One of these stocks is a Dividend King poised to deliver solid growth for years to come. Another offers an ultra-high dividend yield of 9.2% and has a big growth opportunity.
If I Had To Invest $100,000 In Dividend Aristocrats
10:23am, Thursday, 04'th Jul 2024
If I had to invest $100K today in Dividend Aristocrats, here's what I would do. I'd spread my investments in between my top 10 picks within the list. I show you what portfolio profile this would creat
AbbVie Q2 Preview: Upgrade To Buy - Better Late Than Never
09:58am, Thursday, 04'th Jul 2024
AbbVie continues to navigate Humira's LOE brilliantly, with the higher rebates and lower pricing ensuring its market-leading share despite the notable impacts on the top/bottom lines. The manageme
AbbVie cuts 2024 profit forecast on acquisition-related expenses
03:07pm, Wednesday, 03'rd Jul 2024
AbbVie on Wednesday lowered its 2024 adjusted profit forecast as the drugmaker expects to incur $937 million in acquisition-related expenses.
